M207. REVEALING HYPOTHALAMIC PATHWAYS CONTRIBUTION TO OLANZAPINE- INDUCED METABOLIC SYNDROME: FROM MURINE MODEL TO HUMAN TRANSLATION

BACKGROUND: Olanzapine (OL) represents one of the main choices for the treatment of psychotic symptoms. However, OL increase the risk of metabolic syndrome (MS). The mechanism of Olanzapine induced MS remains still unclear but hypothalamic pathways seem to be involved. The purpose of our study is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Veneziani, Federica, Rampino, Antonio, Marakhovskaia, Aleksandra, Quintana, Clementine, Blasi, Giuseppe, Zezza, Marco, Bertolino, Alessandro, Martin Beaulieu, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Session II
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234485/
http://dx.doi.org/10.1093/schbul/sbaa030.519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234485/
http://dx.doi.org/10.1093/schbul/sbaa030.519

Ejemplares similares